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Abstract
Background: Components of the insulin signaling pathway are important regulators of growth.
The FOXO (forkhead box, sub-group "O") transcription factors regulate cellular processes under
conditions of low levels of insulin signaling. Studies in mammalian cell culture show that activation
of FOXO transcription factors causes cell death or cell cycle arrest. The Caenorhabiditis elegans
homologue of FOXO, Daf-16, is required for the formation of dauer larvae in response to
nutritional stress. In addition, FOXO factors have been implicated in stress resistance and
longevity.
Results: We have identified the Drosophila melanogaster homologue of FOXO (dFOXO), which is
conserved in amino acid sequence compared with the mammalian FOXO homologues and Daf-16.
Expression of dFOXO during early larval development causes inhibition of larval growth and
alterations in feeding behavior. Inhibition of larval growth is reversible upon discontinuation of
dFOXO expression. Expression of dFOXO during the third larval instar or at low levels during
development leads to the generation of adults that are reduced in size. Analysis of the wings and
eyes of these small flies indicates that the reduction in size is due to decreases in cell size and cell
number. Overexpression of dFOXO in the developing eye leads to a characteristic phenotype with
reductions in cell size and cell number. This phenotype can be rescued by co-expression of
upstream insulin signaling components, dPI3K and dAkt, however, this rescue is not seen when
FOXO is mutated to a constitutively active form.
Conclusions: dFOXO is conserved in both sequence and regulatory mechanisms when compared
with other FOXO homologues. The establishment of Drosophila as a model for the study of
FOXO transcription factors should prove beneficial to determining the biological role of these
signaling molecules. The alterations in larval development seen upon overexpression of dFOXO
closely mimic the phenotypic effects of starvation, suggesting a role for dFOXO in the response to
nutritional adversity. This work has implications in the understanding of cancer and insulin related
disorders, such as diabetes and obesity.
Background
The biological control of the size of an organism is one of
the most elusive concepts in biology. What mechanisms
determine the size differences between species? What
genetic and environmental factors contribute to variations
of size within a species? How does an individual regulate
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of the body? Although much remains unanswered, it is
clear that the size of an individual is directly related to the
number of cells it has, and the size of these cells [1–3].
Thus, the final size of an organism is determined by the
number of cell divisions that occur during development,
and the amount of growth these cells undergo. When con-
sidering the size difference between two organisms, such
as a mouse and a human, it is obvious that the main cause
of the size difference is the total number of cells [2]. Intu-
itively, this may lead to the conclusion that the size of an
organism is related to the rate of cell proliferation during
development. However, experimental evidence shows
that there are more subtle controls involved [4,5]. For
example, increasing or decreasing cell proliferation in the
Drosophila imaginal discs does not alter the final size, but
instead produces discs with either an increased number of
small cells or a decreased number of large cells [4,5].
These studies indicate that there must be a genetically pre-
determined total cell mass and a mechanism for sensing
this critical size.
Studies in Drosophila demonstrate that the evolutionarily
conserved insulin signaling pathway is involved in the
control of body size, through alterations of cell size and
cell number [1]. Seven Drosophila insulin-like peptides
(Dilps) have been identified that are able to promote
organism growth when expressed ubiquitously during
development [6,7]. The Dilps activate cell signaling
through the Drosophila insulin receptor (dInr), a receptor
tyrosine kinase, which can promote growth when overex-
pressed in the developing eye [6,8]. Loss of function
mutations in dInr are lethal during embryogenesis [8].
However, reduction of dInr levels through combination
of weak heteroallelic mutations [9], or through partial
loss of function mutations[6], reduces growth and leads
to the development of small adults that have reduced cell
size and number. In mammals, the insulin receptor pro-
motes signaling through adaptor proteins, the insulin
receptor substrates (IRS) 1–4, which are required to acti-
vate phosphoinositide-3-kinase (PI3K) [10,11]. PI3K is a
lipid kinase that phosphorylates inositide lipids on the
inner surface of the cell membrane, leading to the activa-
tion of the serine/threonine kinase Akt. Once activated,
Akt phosphorylates many substrates that are involved in
the regulation of metabolism, cell death/survival, and cell
proliferation. Negative regulation of insulin signaling
occurs through the tumor suppressor, PTEN. PTEN
removes phosphates from inositide lipids, thus acting in
opposition to PI3K. This signaling mechanism appears to
be conserved in Drosophila, and the Drosophila homo-
logues of IRS 1–4 (chico), PI3K (dPI3K), Akt (dAkt) and
PTEN (dPTEN) have all been individually implicated in
the regulation of cell size, and cell number [1]. Flies that
are homozygous for a null mutation in chico are smaller
than normal due to a reduction in cell size and cell
number [12]. Null mutations in dAkt are lethal [13], how-
ever, rescue of dAkt mutants through ectopic expression of
dAkt during embryogenesis results in a small fly pheno-
type [14] similar to that seen with chico mutants and
through reduction of dInr activity. Clearly, components of
the insulin signaling pathway act to control body and
organ size through regulation of cell size and cell number
during development.
In addition to developmentally predetermined size con-
trol, many cells and organisms can alter their size accord-
ing to environmental stimuli, such as nutrient limitation.
When Drosophila larvae are raised under nutrient limited
conditions the adults are smaller than well-fed
flies[15,16] This phenomena appears to be phenocopied
in the generation of small adults through inhibition of
Drosophila insulin signaling [6,9,12,14]. Interestingly,
expression of Dilps 3, 5, and 7 has been linked to the avail-
ability of nutrients [7]. These Dilps are produced in neu-
rosecretory cells in the larval brain where they are released
into the circulatory system [7]. These studies indicate that
nutritional signals may regulate body size by modulating
the levels of Dilps 3, 5, and 7 in the body.
Newly hatched Drosophila larvae require a nutritional sig-
nal to initiate the cell cycle in mitotic tissues [17]. Well-fed
larvae increase their body mass very rapidly due to repli-
cation of cells in mitotic tissues. In contrast, larvae
hatched into conditions of amino acid starvation live in a
state of developmental arrest for several days until nutri-
ents become available to initiate the cell cycle[16,17].
Dominant negative inhibition of dPI3K in developing
Drosophila larvae has been shown to phenocopy the
effects of amino acid starvation [18]. Expression of dPI3K
in subsets of cells in the imaginal discs of starved larvae
allows these cells to divide in the absence of nutritional
signals [18]. Expression of dPI3K in the fat bodies of
starved larvae significantly reduces their survival, thus
conferring starvation sensitivity in these larvae [18]. This
suggests that Drosophila insulin signaling may play a pro-
tective role in the response to starvation.
An insulin-like signaling pathway involved in the
response to nutrient limitation also exists in the nema-
tode Caenorhabiditis elegans. When C. elegans are raised
under conditions of nutrient limitation, they enter an
alternate developmental stage called the dauer larvae. The
dauer stage is characterized by arrest of growth at a sexu-
ally immature stage along with altered metabolism to
increase the storage of fat [19]. Mutations in components
of the insulin signaling pathway in C. elegans lead to dauer
larvae formation and increased life span [20–24]. A null
mutation in the C. elegans gene, Daf-16, negates dauer for-
mation and the life expanding effect of these mutationsPage 2 of 14
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dauer formation and seems to be the primary effector
molecule under conditions of low levels of insulin
signaling.
Daf-16 is the C. elegans homologue of a highly conserved
group of Akt phosphorylatable forkhead transcription fac-
tors, the FOXO (forkhead box, subgroup "O") transcrip-
tion factors. These transcription factors were first
discovered as proto-oncogenes, which were disrupted as a
result of chromosomal translocations leading to acute
myeloid leukemia and rabdomyosarcoma[27,28]. Three
versions of FOXO have been identified in humans
(FOXO1, FOXO3a, and FOXO4; formerly known as
FKHR, FKHR-L1, and AFX) and mice (Foxo1, Foxo3, and
Foxo4), and additional homologues have been identified
in zebrafish and chickens[29]. The FOXO transcription
factors share a highly conserved forkhead box DNA bind-
ing domain in the N-terminal half of the protein, and
three highly conserved Akt phosphorylation sites. Mam-
malian cell culture studies have shown that in the absence
of Akt signaling, FOXO is able to activate gene transcrip-
tion and cause cell death, cell cycle arrest, or cell senes-
cence [30,31]. In the presence of activated Akt, FOXO
becomes phosphorylated and is sequestered in the cyto-
plasm through facilitation of 14-3-3 binding [32–35],
and/or disruption of a nuclear localization signal[34,36].
The down-regulation of FOXO in this manner is, possibly,
one of the most important consequences of Akt mediated
signaling.
Based on evidence from studies in C. elegans and mamma-
lian cell culture, it appears that FOXO transcription factors
are a critical mediator of cellular processes under condi-
tions of low levels of insulin signaling. To investigate this
further, we have identified and characterized the Dro-
sophila melanogaster version of FOXO. We show that Dro-
sophila FOXO (dFOXO) retains the conserved domains
seen in other organisms and is involved in the regulation
of growth. Of special interest is that dFOXO appears to
have an effect upon feeding behavior, and may be a key
player in the response of Drosophila larvae to nutritional
stress.
Results
dFOXO retains the functional domains found in Daf-16 
and the mammalian FOXO homologues
The dFOXO gene consists of 10 exons and is spread out
over approximately 31 kb in polytene chromosome sec-
tion 88A within the genomic scaffolding region,
AE003703, of the Berkeley Drosophila Genome Project
(BDGP) (Figure 1A). dFOXO encodes a theoretical protein
of 463 amino acids (Figure 1B). Analysis of the complete
Drosophila genome for additional dFOXO homologues
revealed none.
Alignment of dFOXO with the human homologues of
FOXO and Daf-16a1 using ClustalW [37] (Figure 1B)
revealed that although the overall identity of amino acids
is not high, the identity in the forkhead box DNA binding
domain is between 74 and 86 percent. The Akt phospho-
rylation sites are also well conserved in their relative posi-
tion in the protein, and in sequence. The T1 site is located
at T24 in dFOXO, the S1 site at S160, and the S2 site at
S239. These sites align well with the human FOXO homo-
logues in the ClustalW alignment, however the Daf-16 S1,
and S2 sites are slightly out of line (Fig 1B). All three of the
potential Akt phosphorylation sites in dFOXO fit the Akt
consensus target sequence (RxRxxS/T).
Other notable features found in FOXO homologues
include a DYRK1a phosphorylation site, a 14-3-3 binding
site, a nuclear localization signal (NLS), a nuclear export
signal (NES), and Ral dependent phosphorylation sites. A
DYRK1a phosphorylation site was confirmed experimen-
tally in FOXO1 at S329 [38]. This serine residue is con-
served in human FOXO3a (S324), FOXO4 (S267), Daf-
16a1 (S317), and dFOXO (S248) (Figure 1B). In addition,
the sequence surrounding this site in dFOXO (LS248PI) is
identical to that in FOXO1. The high conservation of this
sequence indicates that dFOXO may be phosphorylated at
this site by the Drosophila homologue of DYRK1a, mini-
brain (mnb).
Binding to 14-3-3 proteins is thought to be an important
part of FOXO sequestration [30,31]. 14-3-3 proteins nor-
mally bind to a consensus site containing a phosphoser-
ine residue, either RSxSPxP, or RxxxSPxP [39]. In the case
of dFOXO, the sequence surrounding the T1 Akt phos-
phorylation site fits the former perfectly, aside from the
substitution of a threonine for a serine. It has been shown
experimentally that 14-3-3 does bind to this site in
FOXO1 [40], FOXO3a [33], and Daf-16[32], hence, it is
likely that this region functions as a 14-3-3 binding site in
Drosophila.
The current model for FOXO deactivation suggests that a
NES exists which causes constitutive localization of FOXO
in the cytoplasm in the absence of a functional NLS [31].
A non-conventional NLS was identified in human FOXO4
from amino acids 180–221 [36]. The corresponding
sequence in dFOXO (amino acids 147–194) is 38% iden-
tical and 66% similar in amino acid content (Figure 1B).
This similarity suggests that this region may act as an NLS
in dFOXO as well. A leucine rich NES has been identified
in FOXO1 (368 MENLLDNLNL 377) and the conserva-
tion of this sequence is quite high FOXO3a, FOXO4, and
Daf-16[30] (Figure 1B). The corresponding region in
dFOXO retains two of the important leucine residues (281
LTGTMADELTL 291). However, the remaining sequencePage 3 of 14
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dFOXO encodes a protein that retains important functional domains found in other FOXO homologues. (A) 
Schematic representation of the dFOXO cDNA clone LD05569 and its location in the genomic scaffolding, region AE003703, 
of the BDGP sequence. (B) ClustalW alignment of the proposed dFOXO amino acid sequence with that of mammalian homo-
logues (FOXO1a, FOXO3a, and FOXO4) and Daf-16a1. Highlighted are: the T1, S1, and S2 Akt target sequences (yellow shad-
ing); the potential DYRK1a/mnb phosphorylation site (arrow, and grey shading); and the forkhead box DNA binding domain 
(black box). "*" indicates nucleotides that are identical in all sequences in the alignment, ":" indicates conserved substitutions, 
according to the chemical nature of the amino acids, and "." indicates semi-conserved substitutions. Colors indicate the chemi-
cal nature of the amino acid; Red = small hydrophobic (including aromatic), Blue = Acidic, Magenta = Basic, and Green = basic 
amino acids with hydroxyl groups and/or amine groups.Page 4 of 14
(page number not for citation purposes)
BMC Developmental Biology 2003, 3 http://www.biomedcentral.com/1471-213X/3/5is more divergent, and may or may not act as an NES in
Drosophila.
FOXO4 has previously been shown to be phosphorylated
in a Ral-dependent manner at threonines 447 and
451[41]. However, these sites do not appear to be con-
served in the other human FOXO homologues, Daf-16, or
dFOXO (Figure 1B), indicating that Ral dependent phos-
phorylation of FOXO may be specific to FOXO4.
Interestingly, the carboxy-terminal three amino acids are
conserved between dFOXO and FOXO1 (VSG). Also,
FOXO3a contains a similar sequence in the final three
amino acids (VPG). In view of this conservation, it is pos-
sible that this tail plays a functional role in FOXO
regulation.
dFOXO expression during development phenocopies 
starvation and alters feeding behavior
Drosophila larvae feed continuously for about 5 days after
egg laying (AEL). During this time the appetite and
growth rate of the larvae is enormous. If young larvae are
deprived of food, they do not grow and tend to disperse
randomly[16,17,42]. When the food supply is replen-
ished, the larvae immediately move towards it and con-
tinue eating until they are close to pupation. If the food
supply is depleted, the larvae will disperse again[42]. We
utilized the UAS/Gal4 ectopic expression system [43] to
overexpress dFOXO in the developing larvae under the
control of the ActGal4 driver[44]. This resulted in com-
plete developmental arrest of the larvae, which remained
as first instar for up to 7 days (Figure 2A), similar to the
life expectancy of starved larvae [16–18]. This trend was
also seen using a constitutively active version of Murine
Foxo1 (mFoxo1) containing an alanine substitution at the
T1 (T24A), and S1 (S253A) Akt phosphorylation sites
(mFoxo1-AA) [45] (Figure 2A). In addition, larvae
expressing dFOXO and mFoxo1-AA were often found to
be wandering far from their food supply. We monitored
feeding behavior by assessing the number of larvae away
from their food at 48 and 72 hours after egg laying (AEL).
Larvae expressing dFOXO and mFoxo1-AA showed a 3–4
fold increase in wandering over larvae expressing Gal4
alone (Figure 2B). Thus, dFOXO expression drastically
alters feeding behavior and is able to induce a starvation
type response in larvae which have an adequate food
supply.
In Drosophila, PI3K consists of an adaptor subunit, dp60,
and a catalytic subunit, dp110. Unexpectedly, expression
of an inhibitory or "dominant negative" version of dp110
(UAS-dPI3K-DN)[46] under the control of the ActGal4 did
not lead to increased larval wandering (Figure 2B). Expres-
sion of this construct also did not appear to inhibit larval
growth, whereas other negative regulators of insulin
signaling do [18]. It is possible that the level of expression
of this construct is not high enough under the control of
the ActGal4 driver to have a complete dominant negative
effect.
Starved larvae which are developmentally arrested are
able to resume growth upon acquisition of food [17]. We
examined if larvae that were expressing dFOXO could
resume growth upon termination of dFOXO expression.
To do this we utilized the hsGal4 driver [47]. dFOXO was
Expression of dFOXO in first instar larvae phenocopies star-vation and ef ects feeding behaviorFigure 2
Expression of dFOXO in first instar larvae phenocop-
ies starvation and effects feeding behavior. Expression 
of dFOXO and mFOXO1-AA early in larval development 
using the (A) ActGal4 and (C) hsGal4 driver lines leads to 
developmental arrest similar to that seen in starved larvae. 
Developmentally arrested larvae are capable of surviving for 
up to seven days after egg laying (AEL). (B) Expression of 
dFOXO (red bars) and mFOXO1-AA (green bars) leads to 
alterations in feeding behavior when compared to controls 
(grey bars). The percentage of wandering larvae is signifi-
cantly greater in larvae expressing dFOXO and mFOXO1-
AA at 48 hours and 72 hours AEL (p = 0.05). Expression of 
dPI3K-DN (blue bars) did not increase larval wandering. (D) 
Developmental arrest is reversible upon removal of dFOXO 
expression (red bars), but not upon removal of mFOXO1-
AA expression (green bars). Grey bars represent the con-
trols. Each bar reflects the average of three separate trials, 
with 50 larvae per trial. Genotypes are; (A-top, B-grey bars) 
w; ActGal4/+, (A-middle, B-red bars) w; ActGal4/+; UAS-
dFOXO/+, (A-bottom, B-green bars) w, UAS-mFoxo1-AA/w; 
ActGal4/+, (C-top, D-grey bars) w; hsGal4/+, (C-middle, D-
red bars), w; hsGal4/UAS-dFOXO, (C-bottom, D-green bars) 
w, UAS-mFoxo1-AA/w; hsGal4/+, (B-blue bars) w; ActGal4/UAS-
dPI3K-DN.Page 5 of 14
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10 minutes every 24 hours. This treatment was sufficient
to inhibit growth while allowing controls to survive to
adulthood with a 48 hour delay in the time to pupation
(Figure 2C). When dFOXO expression was discontinued
after 2, 4, and 6 days of HST, developmentally arrested lar-
vae were able to recover with decreased levels of survival
as time progressed (Figure 2D). Significant lethality was
observed in controls as well suggesting that low survival
rate was partially due to the expression of Gal4, which can
induce apoptosis [48], or the HST itself (Figure 2D). Nev-
ertheless, developmental arrest caused by dFOXO is
clearly reversible as these individuals could be returned to
their normal path of development.
dFOXO performs an analogous function to C. elegans, 
Daf-16
The formation of dauer larvae in C. elegans is a develop-
mental response to nutrient limitation [19]. The dauer lar-
vae provides a temporary defense mechanism allowing
the nematode to persevere until nutrients are available, at
which point development can continue. Interestingly,
constitutive activation of Daf-16 by mutation of its Akt
phosphorylation sites to alanine residues causes obliga-
tory dauer larvae formation[49]. We found a similar result
in the Drosophila larvae using the constitutively active
mFoxo1-AA [45]. This construct had an effect similar to
that of dFOXO when expressed under the control of
ActGal4 (Figure 2A), and hsGal4 (Figure 2C). Upon
removal from HST, larvae expressing mFoxo1-AA did not
resume growth but remained in a state of developmental
arrest until death (Figure 2D). Although a few larvae did
survive to adulthood after 2 days of HST, none of the lar-
vae were able to continue development after 4, or 6 days
of HST (Figure 2D). Out of 450 larvae examined at all
time points, only 10 expressing mFoxo1-AA survived,
when compared to 110 and 180 for larvae expressing
dFOXO, and Gal4 alone, respectively. Presumably this
occurs because Akt is unable to deactivate mFoxo1-AA,
allowing it to continue functioning long after expression
is induced. Taken together, this data suggests that dFOXO
is evolutionarily conserved in function, possibly playing a
role in the response to nutritional adversity, as seen in the
formation of dauer larvae in C. elegans.
dFOXO inhibits growth through alterations in cell size and 
cell number
Expression of dFOXO in the third instar larvae caused sig-
nificant lethality, however, rare flies that did survive were
much smaller than control flies (Figure 3A), showing a
phenotype similar to that caused by mutations in chico
[12], dAkt [14] and dInr [6,9]. Expression of dFOXO under
the control of the ubiquitous low level Gal4 drivers, arma-
dillo-Gal4, and hsGal4 (raised at 25°C with no heat shock)
had very little effect on growth (data not shown). In
contrast, increasing expression of dFOXO using the hsGal4
driver in flies raised at 29°C lead to the development of
small adults, which were approximately half the weight of
control flies (Figures 3B and 3D). Analysis of the wings of
these flies showed that the wing area was reduced by
nearly one third and that this reduction was due to a
decrease in both cell size and cell number (Figures 3C and
3D). SEM analysis of the eyes revealed reductions in both
ommatidia number and ommatidia area, which reflect
cell number and cell size, respectively (Figures 3E and 3F).
These results implicate dFOXO in the control of body size
through alterations in cell size and cell number.
dFOXO reduces growth through alterations in cell size and cell numb rFigure 3
dFOXO reduces growth through alterations in cell 
size and cell number (A) Expression of UAS-dFOXO in the 
third larval instar produces small flies (left) when compared 
to controls (right). w; hsGal4/CyO flies were crossed to w; 
UAS-dFOXO/UAS-dFOXO flies and the progeny were heat 
shocked at 37°C for 4 hours during the early third instar. (B) 
Flies of the genotype w; hsGal4/+; UAS-dFOXO/+ (left) were 
smaller than w; hsGal4/+ (right) flies when raised at 29°C. (C) 
The wings of w; hsGal4/+; UAS-dFOXO/+ flies raised at 29°C 
were smaller than control wings (scale bar = 1 mm). (D) Flies 
expressing dFOXO (red bars) also showed a significant 
reduction in body weight, wing area, cell number, and cell 
size when compared to control flies (grey bars) (p = 0.005). 
(E) Flies expressing dFOXO had smaller eyes than control 
flies (scale bar = 150 µm), and (F) their eyes were reduced in 
both the number of ommatidia and the area of the ommatidia 
(red bars) when compared to controls (grey bars). Geno-
types are; (A-left, B-left, C-top, D-red bars, E-left, F-red bars) 
w; hsGal4/+; UAS-dFOXO/+, (A-right, B-right, C-bottom, D-
grey bars, E-right, F-grey bars).  w; hs-Gal4/+.Page 6 of 14
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conserved between mammals and flies
When dFOXO is expressed in the developing eye under
the control of the GMR-Gal4 driver[50], the eye is smaller,
lacking many ommatidia and nearly all of the mechano-
sensory bristles (Figure 4E). The remaining ommatidia are
arranged in the typical hexahedral array and cross sec-
tional analysis revealed that all of the normal photorecep-
tor cells are present (Figure 4E, data not shown). Thus, it
appears that dFOXO expression causes a reduction in the
number of cells but does not interfere with cellular differ-
entiation and the organization of the ommatidia them-
selves. We have used this eye phenotype to test for
interactions between dFOXO and other components of
the insulin signaling pathway.
Expression of dPI3K-DN under the control of GMR-Gal4
leads to the formation of relatively normal eyes with fewer
and smaller cells[46] (Figure 4B). When dFOXO is co-
expressed in the developing eye with dPI3K-DN the eye is
nearly obliterated (Figure 4F). In contrast, co-expression
of dAkt, and wild type dPI3K with dFOXO causes nearly
complete rescue of the phenotype, restoring the omma-
tidia and nearly all of the mechanosensory bristles (Fig-
ures 4G and 4H). Thus, diminishing insulin signaling
(through overexpression of dPI3K-DN) allows for greater
activity of dFOXO, and enhancing insulin signaling
(through overexpression of dAkt or dPI3K) leads to inhi-
bition of dFOXO activity. Similar results were obtained
using a Murine Foxo1 (mFoxo1) construct (Figure 4 I-L),
indicating that the regulatory mechanisms between these
two proteins is conserved and that they are functionally
interchangeable.
Growth effects of dPI3K and dAkt are masked by 
expression of mFoxo1-AA
The constitutively active mFoxo1-AA construct [45] was
also expressed in the developing eye. Expression of this
construct causes a phenotype similar to that of dFOXO
and mFoxo1, with characteristic lack of ommatidia and
mechanosensory bristles (Figure 4M). When mFoxo1-AA
is co-expressed with dPI3K-DN the eye is nearly
obliterated (Figure 4N), as seen with dFOXO and mFoxo1
(Figures 4F and 4J). Co-expression of mFoxo1-AA with
dPI3K leads to a partial rescue of the phenotype, with still
an obvious lack of ommatidia and mechanosensory bris-
tles (Figure 4O). In contrast, co-expression of mFoxo1-AA
with dAkt does not cause rescue of the ommatidia or
mechanosensory bristles (Figure 4P), indicating that this
construct is not responsive to dAkt signaling. The partial
rescue of the dFOXO phenotype by dPI3K appears to be
mediated through alterations in cell size (Figure 5) rather
than cell number, as there is still an obvious lack of
ommatidia and mechanosensory bristles (Figure 4O).
This data indicates that inactivation of dFOXO is required
for the full effects of growth mediated by dPI3K and dAkt.
dPI3K can increase cell size in the presence of 
constitutively active Foxo
To examine the effect of dFOXO overexpression on cell
size we measured the area of the ommatidia. Expression of
dFOXO, mFoxo1, and mFoxo1-AA caused a significant
reduction in the area of the ommatidia (p = 0.001) (Figure
5). Expression of dPI3K caused a significant increase in
ommatidia size over wild type (p = 0.001) (Figure 5). This
result is consistent with previous studies showing that
dPI3K affects cell size in a cell autonomous manner[46].
Co-expression of dFOXO, mFoxo1, and mFoxo1-AA with
Regulation of dFOXO through insulin signaling is conserved b tween mammals and fliesFig r  4
Regulation of dFOXO through insulin signaling is 
conserved between mammals and flies. The GMR-Gal4 
driver was used to drive the expression of (B) dPI3K-DN, 
(C) wild type dPI3K, (D) dAkt, (E) dFOXO, (I) mFoxo1, and 
(M) mFoxo1-AA, both alone and in various combinations (F-
H, J-L, N-P) as indicated through the rows and columns in 
the figure (scale bar = 150 µm). Genotypes are: (A) w; GMR-
Gal4/+, (B) w; UAS-dPI3K-DN/GMR-Gal4, (C) w; UAS-dPI3K/
GMR-Gal4, (D) w; UAS-dAkt/GMR-Gal4, (E) w; GMR-Gal4/+; 
UAS-dFOXO/+, (F) w; UAS-dPI3K-DN/GMR-Gal4; UAS-dFOXO/+, 
(G) w; UAS-dPI3K/GMR-Gal4; UAS-dFOXO/+, (H) w; UAS-dAkt/
GMR-Gal4; UAS-dFOXO/+ (I) w; GMR-Gal4, UAS-mFoxo1/+, (J) 
w; GMR-Gal4, UAS-mFoxo1/UAS-dPI3K-DN, (K) w; GMR-Gal4, 
UAS-mFoxo1/UAS-dPI3K, (L) w; GMR-Gal4, UAS-mFoxo1/UAS-
dAkt, (M) w, UAS-mFoxo1-AA/w; GMR-Gal4/+, (N) w, UAS-
mFoxo1-AA/w; GMR-Gal4/UAS-dPI3K-DN, (O) w, UAS-mFoxo1-
AA/w; GMR-Gal4/UAS-dPI3K, (P) w, UAS-mFoxo1-AA/w; GMR-
Gal4/UAS-dAkt.Page 7 of 14
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tidia (p = 0.001) (Figure 5). Thus, it appears that FOXO
proteins have a very minimal effect on cell size in the pres-
ence of high levels of dPI3K. Surprisingly, this is the case
even with the mFoxo1-AA construct, which is only par-
tially responsive to PI3K signaling [45]. This indicates that
the dPI3K mediated increase in cell size can occur through
dAkt independent mechanisms.
Expression of dAkt in the developing eye caused a signifi-
cant increase in ommatidia size, similar to that seen with
dPI3K (p = 0.001) (Figure 5). Co-expression of dAkt with
either dFOXO or mFoxo1, cause a slight, but insignificant
decrease in the size of the enlarged ommatidia (Figure 5).
However, co-expression of dAkt with mFoxo1-AA resulted
in ommatidia that were approximately the same size as
the ommatidia in eyes expressing Gal4 alone (Figure 5),
and significantly smaller than the ommatidia in eyes
expressing dAkt alone (p = 0.001) (Figure 5). This indi-
cates that the deactivation of FOXO by dAkt is essential for
dAkt to induce an increase in cell size.
dFOXO may reduce cell number through inhibition of the 
cell cycle and not apoptosis
The lack of ommatidia and mechanosensory bristles
caused by dFOXO expression suggest a reduction in cell
number during eye development (Figure 6A). Reduction
of cell number can occur through either increased cell
death, or decreased of cell proliferation. The Drosophila
inhibitors of apoptosis, Diap1 and Diap2 (data not
shown), and the baculovirus inhibitor of apoptosis, p35
(Figure 6B), were unable to rescue the phenotype caused
by dFOXO expression. In addition, acridine orange stain-
ing of eye imaginal discs expressing dFOXO showed no
increase in apoptosis when compared to controls (data
not shown). Drosophila Epidermal Growth Factor Recep-
tor (dEGFR) signaling acts to protect differentiated cells
from death during eye development [51]. We thought that
the pro-survival effects of dEGFR may be sufficient to sup-
press the phenotype caused by dFOXO overexpression.
Co-expression of dEGFR with dFOXO, however, does not
rescue the dFOXO phenotype as ommatidia and bristles
are clearly still missing (Figure 6D). Conversely, dFOXO
does not appear to affect the phenotype of dEGFR overex-
pression as the general disorganization of the ommatidia
appears to be the same (Figure 6C). Thus, it appears that
these two mechanisms are acting independently. Taken
together, these results suggest that dFOXO overexpression
does not cause cell death during eye development as direct
inhibitors of the apoptotic machinery (p35 and Diap1/2)
and a known cell survival factor (dEGFR) were unable to
rescue the dFOXO phenotype.
Since inhibition of apoptosis could not rescue the pheno-
type caused by dFOXO overexpression in the eye, we
examined if activating the cell cycle could inhibit the
phenotype. Expression of the E2F and Dp transcription
factors has been shown to promote cell proliferation in
the wing imaginal disc[4]. Co-expression of E2F and Dp
with dFOXO was not sufficient to rescue the dFOXO phe-
notype (data not shown). Overexpression of constitu-
tively active dRas1 (dRas1V12) has been shown to induce
ectopic cell proliferation[52] and G1/S progression in the
Drosophila wing disc[53,54]. Co-expression of dRas1V12
with dFOXO was lethal, so we used a constitutively active
version of dRas2 (dRas2V14). Although dRas2 has not
been characterized for its role in cell cycle control, it is
possible that it has a similar function to dRas1. Expression
of UAS-dRas2V14 under the control of GMR-Gal4 led to
extreme overgrowth of the eye, lack of ommatidial organ-
ization, and the formation of huge ommatidia (Figure
6E). Co-expression of dRas2V14 with dFOXO was suffi-
cient to restore many of the ommatidia and
dFOXO inactivation is essential for dAkt, but not dPI3K, mediated in reases in c ll sizeFigure 5
dFOXO inactivation is essential for dAkt, but not 
dPI3K, mediated increases in cell size. Ommatidia area 
was measured as a means to determine the effect of FOXO 
overexpression on cell size. Expression of dFOXO (bar 2), 
mFoxo1 (bar 3), and mFoxo1-AA (bar 4) under the control 
of GMR-Gal4 causes a significant decrease in ommatidia area 
when compared to the expression of Gal4 alone (bar 1). In 
addition, GMR-Gal4 was used to drive the expression of 
dPI3K (bars 5–8), and UAS-dAkt (bars 9–12), either alone 
(grey bars), or in the presence of UAS-dFOXO (red bars), 
UAS-mFoxo1 (light green bars), or UAS-mFoxo1-AA (dark green 
bars). Two sided t-tests were preformed to determine statis-
tical significance (p = 0.001). Genotypes are: (1) w; GMR-Gal4/
+, (2) w; GMR-Gal4/+; UAS-dFOXO/+, (3) w; GMR-Gal4, UAS-
mFoxo1/+, (4) w, UAS-mFoxo1-AA/w; GMR-Gal4/+, (5) w; UAS-
dPI3K/GMR-Gal4, (6) w; UAS-dPI3K/ GMR-Gal4; UAS-dFOXO/+, 
(7) w; GMR-Gal4, UAS-mFoxo1/UAS-dPI3K, (8) w, UAS-mFoxo1-
AA/w; GMR-Gal4/UAS-dPI3K, (9) w; UAS-dAkt/GMR-Gal4, (10) w; 
UAS-dAkt/GMR-Gal4; UAS-dFOXO/+ (11) w; GMR-Gal4, UAS-
mFoxo1/UAS-dAkt (12) w, UAS-mFoxo1-AA/w; GMR-Gal4/UAS-
dAkt.Page 8 of 14
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dFOXO alone (Figure 6A and 6F). A similar effect was
observed upon co-expression of dRas2V14 with mFoxo1
(Figure 6G). In contrast, the loss of ommatidia and bris-
tles seen upon over expression of mFoxo1-AA was not res-
cued by dRas2V14 (Figure 6H). This suggests that dRas2V14
inhibits dFOXO via a dAkt phosphorylation dependent
mechanism.
Discussion
For the most part, the genetic mechanisms that control
size in multicellular organisms are not well understood
[2]. Recently, components of the insulin signaling
pathway have been shown to regulate body size in Dro-
sophila melanogaster through alterations in cell size and cell
number [1,6]. We have identified dFOXO as a negative
controller of growth and organism size, which is regulated
by components of the Drosophila insulin signaling
pathway, dPI3K and dAkt. Through overexpression stud-
ies in the developing eye, we have shown that dFOXO is
regulated by dPI3K and dAkt in a manner that is consist-
ent with the regulatory mechanisms deduced through
studies in C. elegans and mammalian cell culture. In addi-
tion, overexpression of dFOXO in the larvae reduces larval
growth, phenocopies the effects of nutritional stress, and
causes alterations in feeding behavior. With this in mind,
we propose that dFOXO is involved in the response of
Drosophila larvae to nutritional stress.
Conservation of FOXO in Drosophila
The FOXO homologues appear to play an evolutionarily
conserved role in the control of cellular processes under
conditions of low levels of insulin signaling [30,31]. Our
experiments provide three lines of evidence supporting
the conservation of this mechanism in Drosophila. First,
dFOXO shows strong sequence homology to Daf-16 and
the human FOXO homologues (Figure 1B). One signifi-
cant characteristic is the high conservation of the three
consensus Akt phosphorylation sites, suggesting that dAkt
is most likely able to phosphorylate dFOXO in vivo, as
shown biochemically with the mammalian FOXO homo-
logues[33–35]. Second, our experiments show that
dFOXO and mFoxo1 cause nearly identical phenotypic
responses when overexpressed in the developing Dro-
sophila eye (Figure 4, 5 and 6). This suggests that the activ-
ity of these proteins is highly conserved as is observed
when the C. elegans FOXO homologue, Daf-16, is
expressed in mammalian cell culture[32]. Third, the phe-
notypic effects of FOXO overexpression can be modulated
by alterations in the insulin signaling pathway. Reduced
insulin signaling leads to a drastic enhancement of the
phenotype that results from expression of FOXO factors
(Figure 4). In contrast, increased insulin signaling tends to
mask these phenotypes, in a manner that is dependent on
the integrity of the Akt phosphorylation sites (Figures 4
dFOXO responds to dRas2 signaling, but not to inhibitors of apoptosisFigure 6
dFOXO responds to dRas2 signaling, but not to 
inhibitors of apoptosis. GMR-Gal4 was used to drive the 
expression of UAS-dFOXO (A) alone, and in the presence of 
(B) UAS-p35, (D) UAS-dEGFR, (F) UAS-Ras2V14. UAS-Ras2V14 
was also expressed in combination with UAS-mFoxo1 (G) and 
UAS-mFoxo1-AA (H). Scale bars equal 150 µm. Genotypes are: 
(A) w; GMR-Gal4/+; UAS-dFOXO/+, (B) w; GMR-Gal4/UAS-p35; 
UAS-dFOXO/+, (C) w; GMR-Gal4/UAS-dEGFR, (D) w; GMR-
Gal4/UAS-dEGFR; UAS-dFOXO/+, (E) w; GMR-Gal4/UAS-RasV14, 
(F) w; GMR-Gal4/UAS-Ras2V14; UAS-dFOXO/+, (G) w; GMR-
Gal4, UAS-mFoxo1/UAS-Ras2V14, and (H) w, UAS-mFoxo1-AA/w; 
GMR-Gal4/ UAS-Ras2V14.Page 9 of 14
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conserved in Drosophila, and that this will be a very use-
ful system in elucidating the function of FOXO transcrip-
tion factors in a model organism.
Regulation of size by dFOXO
Our results show that ectopic dFOXO expression can
mediate reduction in cell size and cell number (Figures 3,
4, and 5). However, the mechanisms by which these
reductions occur are still unclear. Net reduction in cell
number may occur through decreased cell proliferation or
increased apoptosis. Insulin and other growth factors that
activate PI3K and Akt have been implicated as potent
survival factors in mammalian cell culture [10,11]. They
prevent cell death, in part, by inhibition of FOXO factors
and it has been shown that FOXO3a can upregulate
expression of the pro-apoptotic protein Bim[55]. In Dro-
sophila, reduction of insulin signaling can lead to apopto-
sis in the developing embryo [13,14,56,57]. It is possible
that this increase in apoptosis is a result of dFOXO
activation, however, when dFOXO is expressed in the
developing eye there is no apparent increase in apoptosis,
nor is the phenotype suppressed by inhibition of caspases,
or by co-expression of a known cell survival factor, dEGFR
(unpublished observations, Figure 6). These apparent dis-
crepancies may be the result of tissue specific differences.
In mammalian cell culture, induction of cell death by
FOXO factors seems to be limited to non-transformed
haematopoietic cell lineages [31]. In Drosophila, loss of
dAkt function, inhibition of dPI3K, or overexpression of
dPTEN, all induce cell death in the embryo[13,14]. How-
ever, in imaginal disc cells lacking PI3K function, there is
no increase in apoptosis[58]. Thus, the cells in the embryo
and imaginal discs may react differently to reduced levels
of insulin signaling. Although we do not observe induc-
tion of apoptosis upon dFOXO expression, it is possible
that increased levels of dFOXO activity (eg. through dom-
inant negative inhibition of PI3K) do cause apoptosis.
Studies in mammalian cell culture have implicated FOXO
factors in control of the cell cycle through increased
expression of the cyclin dependent kinase inhibitor
p27Kip1 [59,60]. It is possible that the reduction of cell
number seen upon dFOXO expression is a result of cell
cycle inhibition. Co-expression of an activated version of
Drosophila Ras2 (dRas2V14) was sufficient to increase cell
number in the presence of dFOXO (Figure 6). dRas1 has
been shown to induce growth in Drosophila imaginal
discs [52–54] through activation of dPI3K and the
transcription factor dMyc [53]. Although there is very little
information available about dRas2, it is possible that the
function of dRas2 overlaps with that of dRas1. Expression
of dRas2V14 in the developing eye does cause a phenotype
that suggests overgrowth of cells (Figure 6E), and the
dRas2V14 interaction with dFOXO appears to be
dependent on dAkt signaling (Figure 6H). This is not sur-
prising considering that dRas1 [53] and mammalian Ras
[61] have been shown to activate PI3K signaling. Interest-
ingly, increasing the cell cycle through overexpression of
the transcription factors E2F and Dp did not rescue the
cell number deficit seen upon overexpression of dFOXO
(unpublished observations). This suggests the possibility
that activation of dFOXO may override the function of
other growth promoting factors, such as dMyc, which
mediates dRas1 induced G1/S progression [53]. Support-
ing this, we have observed that increased growth as medi-
ated by dAkt is entirely dependent on its ability to
inactivate dFOXO (Figures 4P and 5). Furthermore,
increased growth mediated by dPI3K appears to be
dependent on dFOXO inactivation with respect to
increased cell number, but not cell size (Figures 4O and
5). In humans, inactivation of FOXO factors may play an
important role in tumor suppression by down regulating
expression of D-type cyclins, thus inhibiting cell cycle pro-
gression and transformation[62]. It will be interesting to
test the interactions between dFOXO and other cell cycle
promoters to determine the extent of dFOXO dominance
over cell proliferation.
In addition to its effect on cell number, dFOXO is able to
control cell size (Figures 3 and 5). The ability of dAkt to
increase cell size is dependent on dFOXO inactivation,
however, dPI3K does not need to inactivate dFOXO to
increase cell size (Figure 5). The difference between dPI3K
and dAkt might be attributed to greater activity of the
UAS-dPI3K transgene. However, expression of these con-
structs individually yields very similar results (Figures 4
and 5) indicating that this is probably not the case. This
suggests that dPI3K may control size through dAkt-inde-
pendent mechanisms. One possibility is through the pos-
itive growth regulator, dS6k[63]. dAkt appears to increase
growth through inhibition of a TSC1/TSC2 (tuberous scle-
rosis) complex[64,65]. This complex acts through inhibi-
tion of dTOR (target of rampamycin) [66], which
promotes growth through activation of dS6K [67,68].
Although it appears that dAkt can upregulate growth
through dS6K, dS6K activity is not reduced in larvae lack-
ing dAkt or dPI3K [67]. These results do not necessarily
suggest that dPI3K and dAkt can not activate dS6K, as
dS6K levels may be maintained through amino acid sig-
nals [66,68]. dS6K activity was shown to be dependent on
phosphoinositide dependent kinase (dPDK1) [67], which
interacts genetically with dAkt, dPI3K, dPTEN, and dInr
[56,69] Thus, it is possible that dPI3K can modulate dS6K
activity through dPDK1, independently of dAkt.
Insulin signaling and stress response
Studies in C. elegans indicate that insulin signaling is a crit-
ical mediator of longevity and stress resistance[70,71].
One of the most well-studied stress responses is the Daf-Page 10 of 14
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tions of starvation and/or crowding. Several lines of evi-
dence indicate that dFOXO may play a similar role in
Drosophila larvae. When Drosophila larvae are deprived
of food prior to 70 hours AEL, they live in a state of devel-
opmental arrest for several days before death. However,
when starved after 70 hours AEL, the larvae are able to
develop into adults that are reduced in size. This alteration
in developmental response has been termed the "70 hour
change" and is likely determined by the minimum size
required for a Drosophila larvae to enter pupation[16].
We have mimicked the "70 hour change" through overex-
pression of dFOXO at different stages of larval develop-
ment, in the presence of ample food (Figures 2 and 3). For
example, ubiquitous high level expression of dFOXO in
the early larvae (i.e. before 70 hours AEL) leads to devel-
opmental arrest, whereas heat shock induced expression
of dFOXO during the third instar (i.e. after 70 hours AEL)
leads to the development of small adults. Second, the nor-
mal development of starved larvae can resume upon the
acquisition of food. Similarly, developmental arrest
caused by expression of dFOXO prior to the "70 hour
change" can be reversed if dFOXO expression is discontin-
ued (Figure 2). Developmental arrest caused by
expression of mFoxo1-AA before the "70 hour change" is
not reversible suggesting a constitutive starvation type
response as seen in C. elegans when Daf-16 phosphoryla-
tion sites are mutated[49]. Interestingly, the reversibility
of FOXO induced arrest has also been observed in mam-
malian cell culture[72]. Third, under conditions of poor
nutrition or crowding larval development does not cease,
but the larval period is extended and small adults are pro-
duced [15]. We have replicated this effect through low
level expression of dFOXO during the course of develop-
ment (Figure 3). Finally, feeding behavior is drastically
altered in larvae expressing dFOXO (Figure 2), causing
them to wander away from their food. These larvae are
often found crawling on the sides and lids of Petri dishes.
This response may provide a selective advantage in the
search for food as seen in C. elegans dauer larvae, which
often crawl up to the highest point possible in hopes of
attaching to passing organisms that could move the larvae
to new locations with better food supply [19]. Taken
together, these results suggest that dFOXO activity may act
to promote survival during times of nutritional stress in a
manner that recapitulates the formation of dauer larvae in
C. elegans. It is tempting to speculate that dFOXO plays a
role in response to other forms of stress, as observed with
Daf-16[70,71]. Mammalian FOXO factors have been
implicated in the protective response to oxidative stress
[73–75] and FOXO factors are upregulated in response to
caloric restriction in rat skeletal muscle [76]. Thus, it is
possible that FOXO factors provide an evolutionarily con-
served switch, by which an organism can alter its
developmental program in order to promote survival
under harsh conditions.
Insulin signaling and feeding behavior
Previously, it was observed that activation of insulin sign-
aling caused larvae to wander away from their food [18].
We have observed a similar effect through overexpression
of dFOXO, which acts in opposition to insulin signaling.
As described previously, it is possible that hyperactivation
of insulin signaling may lead to depletion of the haemol-
ymph by increasing the cellular uptake of nutrients [18].
This would lead to increased hunger and cause the larvae
to wander in search of food. Since PI3K activity is lost
under conditions of starvation [18] it stands to reason that
dFOXO would be active under these conditions. Being a
transcription factor, endogenous dFOXO could activate a
host of genes under conditions of starvation leading to a
"genetic starvation profile". Indeed gene expression is
drastically altered upon starvation[42]. Thus, dFOXO may
induce larval wandering through expression of a sub-set
of genes which are normally active during starvation,
whereas activation of insulin signaling may induce larval
wandering by causing physiological changes that lead to a
false sense of starvation.
Conclusions
We have shown that dFOXO is conserved in sequence and
regulatory mechanisms when compared to homologues
from mammals and C. elegans. Drosophila melanogaster
provides a powerful tool for the analysis of genes in a
whole organism. Thus, future studies in this organism
should provide new insights into the biological function
of the FOXO transcription factors. This may have implica-
tions to the study of cancer and diseases related to insulin,
such as diabetes and obesity. Our data, taken together
with that of others, suggests that dFOXO plays a protective
role in the developmental response of Drosophila larvae
to nutritional stress. Thus, it is possible that dFOXO plays
a functional role in response to multiple forms of stress.
In a world plagued with massive pollution and hunger it
is important that we understand how our bodies react to
starvation and environmental stress.
Methods
Identification and sequence analysis of dFOXO
The human FOXO4 gene was used to search the NCBI
(National Center for Biotechnology Information)
genomic data bank for Drosophila homologues. Dro-
sophila genomic sequences with high homology to
FOXO4 were identified and used to search the Berkeley
Drosophila Genome Project (BDGP) for homologous
cDNAs. This procedure allowed us to identify the clone,
LD05569, which was sub-cloned and sent for sequencing
to Cortec DNA Laboratories, Inc., Kingston, Ontario.
Restriction mapping and sequencing revealed a cDNA ofPage 11 of 14
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sequence of 463 amino acids (Fig 1B). Note that there are
two other potential start codons that may act as sites for
translation initiation, and are located slightly upstream of
the start site we have identified.
Creation of transgenic Drosophila lines and 
overexpression studies
mFoxo1, and mFoxo1-T24A/S253A (AA) clones were gener-
ously provided by Dr. William H. Biggs III [45] and the
dFOXO cDNA, LD05569, was obtained from Research
Genetics. The cDNAs were ligated into the p[PUAST]
expression vector for use of the UAS/Gal4 ectopic expres-
sion system [43]. Transgenic flies were created by injecting
p[PUAST]-FOXO constructs into w1118 Drosophila
embryos. Driver lines, GMR-Gal4 [50], heat shock-Gal4
(hsGal4)[47], and Act5C-Gal4 (ActGal4)[44] were
obtained from the Bloomington stock center, as were the
UAS lines UAS-dEGFR, UAS-dRas2V14, UAS-E2F, UAS-Dp,
UAS-p35, UAS-Diap1, and UAS-Diap2. UAS-dPI3K and
UAS-dPI3K-DN (UAS-dp110D954A) were generously pro-
vided by Dr. Sally Leevers. Heat shock treatment was con-
ducted in a 37°C water bath.
Phenotypic analysis
All experiments were performed at 25°C unless otherwise
stated. For scanning electron micrographs, flies were des-
iccated overnight and coated in gold. Ommatidia area was
measured using NIHimage 6.2 and each value shown is
the mean of 9 measurements, taken from 3 individual
eyes. Due to the low survival rate of males expressing
dFOXO, only females were included in the analysis of
wings and body weight. Flies were raised under non-
crowded conditions and a minimum of 12 flies were
weighed individually to determine average body weight.
Wing area was measured using ImageJ 1.28u, from the
National Institute of Health. Cell size and cell number
were calculated as previously described[63]. A minimum
of 10 wings were analyzed per genotype. Two-sided t-tests
were performed to determine significant differences.
Feeding behavior and phenocopy of starvation using 
ActGal4
The Gal4 driver line w; ActGal4/CyO was crossed to w1118,
w; UAS-dFOXO/UAS-dFOXO, w, UAS-mFoxo1-AA/w, UAS-
mFoxo1-AA, and yw; UAS-dPI3K-DN/UAS-dPI3K-DN.
Since the ActGal4 insertion is not homozygous, we
assumed that only half of the hatched larvae contained
the insertion. This assumption was supported by
observation of the adults arising from each cross. For w;
ActGal4/CyO X w1118 the number of adults produced was
nearly equal to the number of hatched embryos, with
approximately half bearing the CyO balancer chromo-
some. For w; ActGal4/CyO X w; UAS-dFOXO/UAS-dFOXO
and w; ActGal4/CyO X UAS-mFoxo1-AA/w, UAS-mFoxo1-
AA only flies bearing the CyO chromosome survived and
the number of adults was approximately half the number
of the total hatched larvae. Small wandering larvae were
observed only for w; ActGal4/CyO X w; UAS-dFOXO/UAS-
dFOXO and w; ActGal4/CyO X UAS-mFoxo1-AA/w, UAS-
mFoxo1-AA, and in these crosses, only the larvae present in
the food were growing. Thus, we assumed that small wan-
dering larvae were of the genotypes w; ActGal4/+; UAS-
dFOXO/+, and w, UAS-mFoxo1-AA/w; ActGal4/+.
For the feeding behavior assay, embryos were collected on
apple juice agar over ~2 hour time periods, counted, and
transferred to a Petri dish with filter paper that was soaked
in 20% sucrose in PBS. In the center of the Petri dish was
a small piece of standard Drosophila food. At 48 hours
AEL the number of hatched eggs was counted to account
for unfertilized embryos. At both 48 hours and 72 hours
AEL the number of larvae not on the food were counted.
The percent wandering larvae was calculated based on the
number of larvae off the food, the number of hatched
eggs, and the assumption that only half of the total larvae
contained the ActGal4 transgene. The results presented are
the average from three separate trials and statistical signif-
icance was determined using a two-sided t-test. Individual
values were taken from analysis of approximately 50
larvae.
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